706-1041

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
706 (USA) · Dr. Rossi
consented 2013-12-31

AEs

Serious

Dropout signal

–

Adverse events

moderate assessed

Moderate ANXIETY — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-05; relationship: REMOTE

mild assessed

Mild ANXIETY — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-05; relationship: REMOTE

mild assessed

Mild DIARRHOEA — outcome: RECOVERED/RESOLVED; onset 2014-01-07 (study day 8.0); relationship: REMOTE

mild assessed

Mild EXCORIATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-14 (study day 15.0); relationship: NONE

mild assessed

Mild EXCORIATION — outcome: RECOVERED/RESOLVED; onset 2014-01-14 (study day 15.0); relationship: NONE

moderate assessed

Moderate IRRITABILITY — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-15 (study day 16.0); relationship: POSSIBLE

moderate assessed

Moderate IRRITABILITY — outcome: RECOVERED/RESOLVED; onset 2014-01-15 (study day 16.0); relationship: POSSIBLE

mild assessed

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-04 (study day 64.0); relationship: POSSIBLE

mild assessed

Mild PRURITUS — outcome: RECOVERED/RESOLVED; onset 2014-03-04 (study day 64.0); relationship: POSSIBLE

Data queries

No data queries.